login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
SILENCE THERAPEUTICS PLC-ADR (SLN) Stock News
USA
- NASDAQ:SLN -
US82686Q1013
-
ADR
4.51
USD
-0.37 (-7.58%)
Last: 9/12/2025, 8:17:19 PM
4.65
USD
+0.14 (+3.1%)
After Hours:
9/12/2025, 8:17:19 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
SLN Latest News, Press Relases and Analysis
All
Press Releases
11 days ago - By: Silence Therapeutics plc
Silence Therapeutics to Participate in September Investor Conferences
a month ago - By: The Motley Fool
Silence (SLN) Q2 Revenue Drops 71%
a month ago - By: Silence Therapeutics plc
Silence Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
3 months ago - By: Silence Therapeutics plc
Silence Therapeutics Presents Additional Phase 1 Data Highlighting Promise of Divesiran as the Potential First-in-Class siRNA Treatment for Polycythemia Vera
6 months ago - By: Benzinga
Deep Dive Into Silence Therapeutics Stock: Analyst Perspectives (7 Ratings)
7 months ago - By: Benzinga
- Mentions:
SSP
CLCO
CVEO
DCI
...
Earnings Scheduled For February 27, 2025
3 months ago - By: Zacks Investment Research
Wall Street Analysts Think Silence Therapeutics (SLN) Could Surge 556.19%: Read This Before Placing a Bet
4 months ago - By: Zacks Investment Research
Wall Street Analysts Believe Silence Therapeutics (SLN) Could Rally 590.66%: Here's is How to Trade
4 months ago - By: Silence Therapeutics plc
Silence Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights
4 months ago - By: Silence Therapeutics plc
Silence Therapeutics Welcomes Tim McInerney to Board of Directors
5 months ago - By: Yahoo Finance
- Mentions:
ERJ
PYPL
BKR
VRNA
...
Silence Therapeutics plc (SLN): Among Takeover Rumors Hedge Funds Are Buying
6 months ago - By: Silence Therapeutics plc
Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference
7 months ago - By: Silence Therapeutics plc
Silence Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
7 months ago - By: Silence Therapeutics plc
Silence Therapeutics to Report Fourth Quarter and Full Year 2024 Results on February 27, 2025
a year ago - By: InvestorPlace
SLN Stock Earnings: Silence Therapeutics Reported Results for Q2 2024
a year ago - By: BusinessInsider
SLN Stock Earnings: Silence Therapeutics Reported Results for Q2 2024
9 months ago - By: Silence Therapeutics plc
Silence Therapeutics Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting
10 months ago - By: Silence Therapeutics plc
Silence Therapeutics to Participate in Fireside Chat at Piper Sandler 36th Annual Healthcare Conference
10 months ago - By: Silence Therapeutics plc
Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association (AHA) Annual Meeting
10 months ago - By: Silence Therapeutics plc
Silence Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
10 months ago - By: Silence Therapeutics plc
Silence Therapeutics to Participate in Fireside Chat at the Jefferies London Healthcare Conference
a year ago - By: Silence Therapeutics plc
Silence Therapeutics to Webcast Presentations at Upcoming September Investor Conferences
a year ago - By: Silence Therapeutics plc
Silence Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
a year ago - By: InvestorPlace
- Mentions:
ALNY
CRSP
The 3 Best Gene Editing Stocks to Buy in August 2024
Please enable JavaScript to continue using this application.